CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (ALNY), the leading RNAi therapeutics company, announced today that it has entered into separate, privately negotiated repurchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results